MicroStrategy might soon join the Nasdaq 100, potentially replacing Moderna, thanks to its recent Bitcoin-fueled stock surge. Analysts Eric Balchunas and James Seyffart predict that the inclusion could happen this Friday, with the official listing on December 23. This move would mark a significant milestone for the company, which has become one of the top 100 publicly traded firms in the U.S.
Currently, MicroStrategy is classified as a tech stock, allowing it to bypass Nasdaq’s restrictions on financial companies. However, this classification could be re-evaluated in March, posing a potential obstacle. Seyffart noted that while the company’s heavy investment in Bitcoin ties its performance to the cryptocurrency market, its status as a tech stock remains unchanged for now.
Driven by consecutive Bitcoin purchases, MicroStrategy’s stock has soared by 500% this year. Despite its transformation into a major Bitcoin holder, Nasdaq still considers it a tech company. This distinction allows it to meet the criteria for inclusion in the index, provided there are no reclassification changes before the deadline.
Balchunas suggested the addition of MicroStrategy to the Nasdaq 100 would reflect its rising prominence, particularly as a leader in corporate Bitcoin adoption. Seyffart agreed, highlighting that reclassification risks remain the main hurdle for the company’s potential inclusion. For now, the final decision rests with Nasdaq, and an announcement is expected by the end of this week.
MicroStrategy’s inclusion would also spotlight Nasdaq’s evolving relationship with cryptocurrency. While the exchange has made limited entries into the crypto space, it facilitated BlackRock’s Ethereum ETF options earlier this year. The decision to add MicroStrategy could signal greater openness to crypto-related companies in the future.
This potential move underscores how Bitcoin’s influence can reshape traditional market dynamics, positioning MicroStrategy as a key player in both the tech and crypto sectors. Whether the company secures its spot in the Nasdaq 100 will depend on upcoming decisions, but for now, it remains a strong contender for this significant milestone.
